Gene-editing Xenograft Model
Advanced Xenograft Services for Precision Oncology Research
In Vivo Services
Gene-editing Xenograft Model Overview
Kyinno Bio develops custom xenograft tumor models with precise genetic modifications, allowing researchers to:
✔ Knock out, knock in, or overexpress specific genes to investigate tumor progression.
✔ Replicate patient-derived mutations for personalized medicine studies.
✔ Evaluate the efficacy of targeted therapies in relevant cancer models.
✔ Predict patient responses to novel anti-cancer treatments.

Gene-edited xenograft tumor models, such as CRISPR/Cas9, are employed to modify the genome of tumor cells by knocking out, overexpressing, or knocking in genes to simulate the occurrence and development of human cancer and to study specific targets. These models are valuable for investigating the mechanisms of cancer development, testing the efficacy of new drugs, and predicting patient responses to anti-cancer treatments. KYINNO has established thousands of gene-edited cell models, encompassing both human tumor cells and mouse-derived tumor cells, providing a powerful tool for scientific research.
Gene-Editing Xenograft Model Workflow
Our gene-editing xenograft services follow a structured approach, ensuring precision and reproducibility in preclinical cancer research:
1️⃣ Genome Editing & Cell Line Development – Using CRISPR/Cas9 to modify human or mouse-derived tumor cells.
2️⃣ Tumor Model Establishment – Engrafting gene-edited cells into immunodeficient or syngeneic mouse models.
3️⃣ Therapeutic Testing & Drug Screening – Evaluating drug responses in vivo.
4️⃣ Tumor Growth Monitoring & Imaging – Using bioluminescence, fluorescence, or PET imaging for real-time tracking.
5️⃣ Comprehensive Data Analysis – Assessing oncogene activity, resistance pathways, and drug efficacy.
Our gene-editing xenograft models are designed for highly targeted preclinical investigations, ensuring reliable and translatable results.
Advantages of Our Xenograft Services
Kyinno Bio’s gene-editing xenograft models provide a flexible and reliable platform for studying genetic drivers of cancer. Key advantages include:
✔ Customizable CRISPR/Cas9 Gene Editing – Enabling precise genetic modifications.
✔ Diverse Tumor Models – Covering solid tumors, hematological malignancies, and rare cancers.
✔ Human & Mouse-Derived Cell Lines – Supporting cross-species genetic research.
✔ Integrated Drug Screening Capabilities – Testing novel kinase inhibitors, immunotherapies, and chemotherapies.
✔ Validated in Preclinical & Translational Research – Providing highly predictive in vivo data.
Using state-of-the-art gene-editing technologies, our xenograft services support high-throughput oncology research and targeted drug development.
Expert Support for Xenograft Model Development
Our team provides comprehensive support throughout gene-edited xenograft development:
- Custom Model Design & Consultation – Developing xenografts tailored to research needs.
- Genomic Validation & Quality Control – Ensuring accurate gene modifications.
- Real-Time Tumor Monitoring – Supporting bioluminescence, PET, and MRI imaging.
- Regulatory Guidance for IND Applications – Assisting in preclinical data generation.
Our expertise in gene editing, xenograft model development, and oncology research, we help researchers generate high-quality, translatable preclinical data.
How to Get Started with Kyinno Bio
Enhance your preclinical oncology research with Kyinno Bio’s xenograft services. Our custom gene-editing xenograft models support oncogene research, targeted therapy validation, and immuno-oncology drug testing.
We provide customized in vivo study designs, ensuring high-quality, data-driven insights for drug development. Contact us today to explore how our xenograft services can support your research.
Frequently Asked Questions (FAQs) About Xenograft Services
All In Vivo Services